Gonadorelin (GnRH)
FDA ApprovedGonadotropin-Releasing Hormone | GnRH Agonist
Community Research
Join others researching Gonadorelin — share findings, ask questions, and learn from real experiences
Gonadorelin is a synthetic form of the naturally occurring gonadotropin-releasing hormone (GnRH). It stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn regulate testosterone production in men and ovulation in women. It is FDA-approved for diagnostic testing and fertility treatment. The pulsatile nature of GnRH secretion is critical for proper reproductive function.
Gonadorelin acts as an agonist of the GnRH receptor in the anterior pituitary. When administered in pulses (mimicking natural secretion patterns every 60-120 minutes), it stimulates release of FSH and LH. LH then stimulates Leydig cells in the testes to produce testosterone, or triggers ovulation in women. Continuous exposure paradoxically causes receptor downregulation and suppressed hormone production.
Molecular Data
?HWSYGLRPG?pGlu
Position 1
Histidine
Position 2
Tryptophan
Position 3
Serine
Position 4
Tyrosine
Position 5
Glycine
Position 6
Leucine
Position 7
Arginine
Position 8
Proline
Position 9
Glycine
Position 10
NH2
Position 11
Research Indications
Treatment of conditions like Kallmann syndrome where GnRH deficiency causes low testosterone and infertility.
Induces ovulation in women with hypothalamic amenorrhea who don't ovulate regularly.
Stimulates testosterone and sperm production by restoring LH/FSH pulsatility.
Treatment of delayed puberty due to hypothalamic-pituitary dysfunction.
Used to assess hypothalamic-pituitary function and diagnose GnRH deficiency.
Evaluates pituitary reserve and responsiveness to GnRH stimulation.
Maintains testicular function and fertility during testosterone replacement therapy.
Helps restore natural testosterone production after anabolic steroid use.
Treatment of undescended testes in pediatric patients.
Dosing Protocols
Can be administered as single injections or via pulsatile infusion pump. Single injections are used for diagnostic testing, while pulsatile administration mimics natural GnRH secretion for therapeutic purposes. Very short half-life (10-40 minutes) requires careful dosing strategy.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Diagnostic testing | 100 mcg | Single injection | SubQ or IV |
| Fertility support | 50-100 mcg | 2-3x weekly | SubQ |
| Pulsatile therapy | 5-20 mcg per pulse | Every 90-120 min | SubQ pump |
| TRT adjunct | 100-200 mcg | 2-3x weekly | SubQ |
Reconstitution Instructions
- Bacteriostatic water (BAC)
- Insulin syringes (0.5-1 mL)
- Alcohol swabs
- Peptide vial
- Sterile work surface
- 1 Clean work area and hands thoroughly
- 2 Calculate required BAC water volume
- 3 Draw BAC water into syringe
- 4 Inject slowly down vial side (not directly onto powder)
- 5 Gently swirl until dissolved (never shake)
- 6 Store in refrigerator, use within 14 days
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Injection site reactions
- Headache
- Flushing
- Nausea
- Abdominal discomfort
Stop Signs - Discontinue if:
- Signs of allergic reaction (rash, difficulty breathing)
- Severe headaches
- Unusual abdominal pain
Contraindications
- Hormone-sensitive tumors
- Pregnancy
- Hypersensitivity to GnRH or analogs
- Conditions worsened by sex hormone release
Quality Checklist
Good Signs
- White lyophilized powder
- Clear solution after reconstitution
- Intact vacuum seal
Warning Signs
- Slight clumping that dissolves easily
Bad Signs
- Discolored powder
- Cloudy or particulate solution
- Broken seal
Frequently Asked Questions
Why is pulsatile Gonadorelin dosing critical, and what happens with continuous dosing?
Gonadorelin must be dosed in pulses (every 90-120 minutes) to mimic natural GnRH secretion patterns. Continuous exposure paradoxically causes GnRH receptor desensitization and downregulation, suppressing LH and FSH release—the opposite of desired effects. Proper pulsatile timing is essential for therapeutic success.
Is Gonadorelin better than hCG for maintaining testicular function during TRT?
Both Gonadorelin and hCG maintain testicular function and fertility during TRT, but they work differently. hCG directly mimics LH with a 24-36 hour half-life, while Gonadorelin stimulates natural LH/FSH release but requires pulsatile dosing. hCG is simpler to administer; Gonadorelin offers more physiological restoration of the HPG axis.
How quickly does Gonadorelin raise testosterone after injection?
Gonadorelin has an extremely short 2-4 minute half-life, triggering LH release within minutes. Testosterone elevation from LH stimulation begins within hours, with peak levels at 6-12 hours post-injection. This rapid response makes it suitable for diagnostic testing and pulsatile protocols.
Can Gonadorelin be used long-term for post-cycle therapy, or just short-term?
Gonadorelin is effective for both acute (diagnostic) use and extended post-cycle protocols lasting 2-3 weeks. However, its extreme sensitivity to dosing frequency makes it less practical long-term than hCG or clomiphene. Most PCT protocols use Gonadorelin initially then transition to other agents for maintenance.
References
- Gonadorelin in Hypogonadotropic HypogonadismJournal of Clinical Endocrinology & Metabolism (2018)
Pulsatile GnRH administration effectively restores fertility in patients with hypothalamic hypogonadism.
- GnRH Pulsatility and Reproductive FunctionFrontiers in Endocrinology (2020)
Pulsatile GnRH secretion (every 60-120 min) is essential for proper FSH/LH release and reproductive function.
- Gonadorelin for Ovulation InductionFertility and Sterility (2015)
Effective treatment for ovulation induction in women with hypothalamic amenorrhea.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.